Premier Biomedical, Inc. (OTCMKTS:BIEI) Short Interest Update

Premier Biomedical, Inc. (OTCMKTS:BIEI) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 80,300 shares, an increase of 101.8% from the February 28th total of 39,800 shares. Based on an average daily trading volume, of 5,645,000 shares, the short-interest ratio is currently 0.0 days.

Premier Biomedical Trading Up 25.0 %

Shares of OTCMKTS BIEI traded up $0.00 during trading hours on Friday, reaching $0.00. 40,000 shares of the stock were exchanged, compared to its average volume of 3,774,182. Premier Biomedical has a 52 week low of $0.00 and a 52 week high of $0.00.

About Premier Biomedical

Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors.